Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
Rank in Stocks #5711
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Share Price
$5.21
Market Cap
$2.49B
Change (1 day)
-0.91%
Change (1 year)
-34.46%
Country
CN
Trade Bloomage BioTechnology Corporation Limited (688363)
Stock split history for Bloomage BioTechnology Corporation Limited (688363)
Bloomage BioTechnology Corporation Limited stock (symbol: 688363) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 27, 2026.
One 688363 share bought prior to Aug 27, 2026 would equal to 0 688363 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
GB
0 -
FR
6 x95
US
4 x15
US
8 x18
US